The first annual BioNorthTX iC3 Life Science Summit kicks off Wednesday, Sept. 30, at the Dallas Marriott Las Colinas hotel in Irving, Texas. The networking, education and business development conference for investors, researchers and life science companies is designed to showcase innovation, collaboration and commercialization efforts aimed at making North Texas the US life sciences industry’s “3rd coast.”
An independent not-for-profit 501(c)(6) trade association serving and representing the life sciences industry in northern Texas, BioNorthTX’s mission is to encourage development of a rich ecosystem for promoting growth and success of North Texas life science companies, as well as strengthening the economy of the region’s local communities. The industry driven organization seeks to highlight North Texas life sciences successes and assets, including academic research, member organizations’ activities and goals, and available resources. It was conceived and created to productively assist participant members with development of ecosystem changing initiatives that benefit the whole industry in the north Texas region. Membership includes both organizations and individuals engaged in, or supportive of, research, development and commercialization of life science technologies.
Membership in BioNorthTX, which held its first Board of Directors meeting at The Foundry in Dallas in April, includes companies and organizations working in fields that include: Biotechnology, Medical Device & Equipment, Pharmaceuticals & Therapeutics, Nanotechnology, Agricultural Biotechnology, and Product Development/Drug Discovery Firms. A full list of BioNorthTX partners can be found at: http://bionorthtx.org/members/
BioNorthTX is dedicated to filling a major gap in the North Texas biotech and life sciences industries by promoting the convergence of life science research and supporting industries. One of the iC3 Summit goals is providing a forum for life science (biotechnology, medical device, pharmaceutical) company executives, academic professionals, investors, and industry support organizations, and an opportunity to meet in one place as part of the region’s largest annual conference bringing together all regional industry participants, and to raise awareness among regional businesses at large of North Texas’s potential to become a leader in bioscience innovation.
Both emerging and established life science, biopharma, pharma, and healthcare companies as well as academic research institutions, innovators and industry leaders will attend the iC3 Summit, as well as business development executives, vendor partners, investors, and other biotech business professionals interested in expanding their business in the North Texas region.
The Summit program will include an opening plenary session breakfast, a keynote address by The Honorable James Greenwood, CEO of the Washington, DC based Biotechnology Industry Organization which represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. Keynotes will also be delivered by Tom Kowalski, CEO and President of the Texas Healthcare and Bioscience Institute (THBI), in Austin, and Dr. Dennis Stone MD, Chief Scientific Officer and Director of Remeditex in Dallas; a lunch keynote on the 30th by Allan May, founder and chairman of Life Science Angels, Inc. — the largest angel organization in the U.S. focused solely on early stage medical device and life science start-ups, comprised solely of high net worth individuals from the medical device or biotech fields; and an afternoon investment session.
Other Summit highlights will include a North Texas company CEO panel, in which key opinion leaders will discuss their companies’ operational strategies and successes, and a North Texas research organizations showcase with exhibit booths from key regional support organizations accessible to attendees. Job seekers and post docs will also have the opportunity to interact with potential hiring executives during the summit, which will close with a Cocktail reception for attendees.
The iC3 Summit follows the Breakfast Forum event held on August 31 hosted by founding member organization Baylor Research Institute (BRI), a Dallas-based research center dedicated to researching and developing patient-focused prevention therapies and treatments for diseases and illnesses. Two BRI employees also serving on the iC3 Life Sciences Summit planning committee are Jaime Walkowiak, vice president of clinical research operations who leads Baylor Research Institute’s clinical research activities and development programs with an emphasis on professionalism and quality of support to principal investigators, and Melissa Acosta, PhD, a patent liaison in the Intellectual Property Protection Office whose work includes patents relating to Microfluidic devices, anti-viral vaccines for diseases such as Rotavirus and Norwalk virus, cancer therapeutics and therapeutic methods using nucleic acid compositions, protein compositions or other small molecule compositions. As BRI’s patent liaison, Dr. Acosta is responsible for the management and administrative oversight of BRI’s entire patent portfolio.
Established in 1984 in Dallas, Texas, Baylor Research Institute promotes and supports research to transfer innovative treatments from laboratory workbench to patient bedside, and in aid of achieving this bench-to-bedside concept, BRI focuses on basic science, clinical trials, health care effectiveness and quality-of-care research projects in areas ranging from human immunology and orphan metabolic diseases to diabetes, cardiovascular disease and many other unmet medical needs.
Baylor Scott & White Health, an organization formed from the 2013 merger of Baylor Health Care System and Scott & White Healthcare, is today the largest not-for-profit health care system in Texas with total assets of $9 billion (2014), and serving a population larger than the state of Virginia with its 49 hospitals, more than 800 access points, more than 5,800 active physicians, 35,000 employees and the Scott & White Health Plan.
The iC3 Summit could not be held without the generous support of members and sponsors. As a newly formed non-profit, BioNorthTX relies on this support and offers several levels of opportunities to participate. For more sponsorship information, email info(at)bionorthtx.org.
For more information about, and/or to register for the iC3 Life Sciences Summit, visit http://bionorthtx.org.
Baylor Research Institute
Baylor Research Institute
Biotechnology Industry Organization
Angel Resource Institute